If you find this podcast useful please give it a rating and review on iTunes by clicking here
Intelligent UItrasound (IUG) chief executive Stuart Gall talks us through the company's impressive first-half results and how the company's "classroom-to-clinic" strategy is set to deliver further growth in the coming years.
In the first six-months of 2022, the company grew revenues by 62% to £5.9m, leaving it well on track to hit its £10m full year target and taking it ever closer to breakeven. Growth was driven by a strong performance in its core simulation business, as large NHS contracts offset a slowdown in China as a result of its zero-Covid policy.
Encouragingly, the Clinical AI business grew sales fivefold, with expansion of its relationship with key partner GE Healthcare after the period-end - which took its ScanNav AI software onto its biggest-selling machine, the Voluson Expert 22 - and further product launches in the second half are expected to lead to further rapid growth.